Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

par Dei Cas, Alessandra, Spigoni, Valentina, Cito, Monia, Aldigeri, Raffaella, Ridolfi, Valentina, Marchesi, Elisabetta, Marina, Michela, Derlindati, Eleonora, Aloe, Rosalia, Bonadonna, Riccardo C., Zavaroni, Ivana
Publié dans Cardiovasc Diabetol (2017)